Dijkstra MK - Search Results

1

Expression of a passenger miR-9* predicts favorable outcome in adults with acute myeloid leukemia less than 60 years of age.

Nowek K, Sun SM, Dijkstra MK, Bullinger L, Döhner H, Erkeland SJ, Löwenberg B, Jongen-Lavrencic M. Nowek K, et al. Among authors: dijkstra mk. Leukemia. 2016 Feb;30(2):303-9. doi: 10.1038/leu.2015.282. Epub 2015 Oct 14. Leukemia. 2016. PMID: 26464168

2

Aberrant expression of miR-9/9* in myeloid progenitors inhibits neutrophil differentiation by post-transcriptional regulation of ERG.

Nowek K, Sun SM, Bullinger L, Bindels EM, Exalto C, Dijkstra MK, van Lom K, Döhner H, Erkeland SJ, Löwenberg B, Jongen-Lavrencic M. Nowek K, et al. Among authors: dijkstra mk. Leukemia. 2016 Jan;30(1):229-37. doi: 10.1038/leu.2015.183. Epub 2015 Jul 15. Leukemia. 2016. PMID: 26174629

3

The prognostic relevance of miR-212 expression with survival in cytogenetically and molecularly heterogeneous AML.

Sun SM, Rockova V, Bullinger L, Dijkstra MK, Döhner H, Löwenberg B, Jongen-Lavrencic M. Sun SM, et al. Among authors: dijkstra mk. Leukemia. 2013 Jan;27(1):100-6. doi: 10.1038/leu.2012.158. Epub 2012 Jun 13. Leukemia. 2013. PMID: 22692398

4

Transition of highly specific microRNA expression patterns in association with discrete maturation stages of human granulopoiesis.

Sun SM, Dijkstra MK, Bijkerk AC, Brooimans RA, Valk PJ, Erkeland SJ, Löwenberg B, Jongen-Lavrencic M. Sun SM, et al. Among authors: dijkstra mk. Br J Haematol. 2011 Nov;155(3):395-8. doi: 10.1111/j.1365-2141.2011.08682.x. Epub 2011 May 9. Br J Haematol. 2011. PMID: 21554257 Free article. No abstract available.

5

The chromatin remodelling factor BRG1 is a novel binding partner of the tumor suppressor p16INK4a.

Becker TM, Haferkamp S, Dijkstra MK, Scurr LL, Frausto M, Diefenbach E, Scolyer RA, Reisman DN, Mann GJ, Kefford RF, Rizos H. Becker TM, et al. Among authors: dijkstra mk. Mol Cancer. 2009 Jan 16;8:4. doi: 10.1186/1476-4598-8-4. Mol Cancer. 2009. PMID: 19149898 Free PMC article.

6

17p13/TP53 deletion in B-CLL patients is associated with microRNA-34a downregulation.

Dijkstra MK, van Lom K, Tielemans D, Elstrodt F, Langerak AW, van 't Veer MB, Jongen-Lavrencic M. Dijkstra MK, et al. Leukemia. 2009 Mar;23(3):625-7. doi: 10.1038/leu.2008.264. Epub 2008 Sep 25. Leukemia. 2009. PMID: 18818704 No abstract available.

7

miRNA analysis in B-cell chronic lymphocytic leukaemia: proliferation centres characterized by low miR-150 and high BIC/miR-155 expression.

Wang M, Tan LP, Dijkstra MK, van Lom K, Robertus JL, Harms G, Blokzijl T, Kooistra K, van T'veer MB, Rosati S, Visser L, Jongen-Lavrencic M, Kluin PM, van den Berg A. Wang M, et al. Among authors: dijkstra mk. J Pathol. 2008 May;215(1):13-20. doi: 10.1002/path.2333. J Pathol. 2008. PMID: 18348159

8

MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia.

Jongen-Lavrencic M, Sun SM, Dijkstra MK, Valk PJ, Löwenberg B. Jongen-Lavrencic M, et al. Among authors: dijkstra mk. Blood. 2008 May 15;111(10):5078-85. doi: 10.1182/blood-2008-01-133355. Epub 2008 Mar 12. Blood. 2008. PMID: 18337557 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters